CHE
Chemed Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+34/100
Last price
509.84
▼ 1.46 (0.29%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
511.99
Prev close
511.30
Day high
517.98
Day low
506.32
Volume
129.21K
Market cap
$6.66B
P/E (TTM)
25.72
52W range
365.21 – 557.00
Day trading desk
Gap from prior close
+0.13%
Prior close 511.30
VWAP
509.97
-0.03% from price
Relative volume
1.32×
Normal
Session range
2.30%
506.32 – 517.98
Position in range
30%
Mid range
ATR (14D)
12.21
2.39% of price
Prior day high
514.46
PDH
Prior day low
500.97
PDL
Bid / ask spread
—
Quote not published
Session volume
211.76K
Avg 160.10K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.43%
-2.4%
1M
-1.92%
-3.1%
3M
+6.27%
+1.8%
6M
+31.08%
+12.9%
YTD
+19.16%
+4.9%
1Y
+14.96%
-1.5%
3Y
-1.90%
-84.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CHE open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+20.72K
Net buying
Buy transactions
12
30.82K shares
Sell transactions
8
10.10K shares
Net transactions
+20
Buys less sells
Sell : buy shares
0.3 : 1
Mixed
Insider-held shares
252.49K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 30, 26 | LEE SPENCER S Officer |
CONVERSION | 12.10K | $5.39M | Direct |
| Sep 28, 26 | HUTTON THOMAS CHARLES Officer and Director |
CONVERSION | 4.63K | $2.06M | Direct |
| Sep 28, 26 | MCNAMARA KEVIN J Chief Executive Officer |
SELL | 2.00K | $1.03M | Direct |
| Sep 18, 26 | MCNAMARA KEVIN J Chief Executive Officer |
SELL | 2.00K | $1.00M | Direct |
| Aug 10, 26 | JUDKINS BRIAN C Officer |
CONVERSION | 6.79K | $3.02M | Direct |
| Aug 5, 26 | WHERLEY JOEL L Officer |
CONVERSION | 2.60K | $1.16M | Direct |
| Aug 3, 26 | MCNAMARA KEVIN J Chief Executive Officer |
SELL | 2.00K | $1.08M | Direct |
| Jul 31, 26 | MCNAMARA KEVIN J Chief Executive Officer |
CONVERSION | 2.00K | $891.14K | Direct |
| Jul 31, 26 | GRACE PATRICK P Director |
SELL | 190 | $101.08K | Direct |
| Jun 9, 26 | LINDELL ANDREA R Director |
SELL | 1.35K | $602.55K | Direct |
| May 29, 26 | WALSH GEORGE J III Director |
SELL | 500 | $218.91K | Direct |
| May 18, 26 | DELYONS RON Director |
STOCK | 386 | $170.14K | Direct |
| May 18, 26 | MCCARTHY EILEEN P Director |
STOCK | 386 | $170.14K | Direct |
| May 18, 26 | MOUNT JOHN MEREDITH JR. Director |
STOCK | 386 | $170.14K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
DELYONS RON |
Director | 2.05K | Stock Award(Grant) |
GRACE PATRICK P |
Director | 3.53K | Sale |
HEANEY CHRISTOPHER J |
Director | 2.77K | Stock Award(Grant) |
HUTTON THOMAS CHARLES |
Officer and Director | 32.84K | Conversion of Exercise of derivative security |
JUDKINS BRIAN C |
Officer | 3.34K | Conversion of Exercise of derivative security |
LEE SPENCER S |
Officer | 14.85K | Conversion of Exercise of derivative security |
LINDELL ANDREA R |
Director | 4.58K | Sale |
MCNAMARA KEVIN J |
Chief Executive Officer | 66.42K | Sale |
WALSH GEORGE J III |
Director | 3.64K | Sale |
WITZEMAN MICHAEL D. |
Chief Financial Officer | 5.95K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$6.66B
Enterprise value$6.89B
Revenue (TTM)$2.60B
Gross profit$859.31M
EBITDA$416.92M
Net income$274.99M
EPS (TTM)$19.82
Free cash flow$307.86M
Total cash$40.22M
Total debt$294.79M
Book value / share$63.81
Shares outstanding13.07M
Float11.85M
Short % of float5.89%
Dividend yield0.55%
Beta (5Y)0.51
Valuation & profitability ratios
Trailing P/E25.72
Forward P/E18.53
PEG ratio1.87
Price / sales—
Price / book7.99
EV / revenue2.66
EV / EBITDA16.53
Gross margin33.11%
Operating margin13.25%
Profit margin10.60%
Return on equity27.11%
Return on assets13.45%
Debt / equity35.50
Current ratio0.91
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.53B | $2.43B | $2.26B | $2.13B | +4.1% |
| Operating revenue | $2.53B | $2.43B | $2.26B | $2.13B | +4.1% |
| Cost of revenue | $1.71B | $1.58B | $1.47B | $1.37B | +8.2% |
| Gross profit | $823.18M | $854.35M | $798.82M | $765.09M | -3.6% |
| Selling, general & admin | $417.19M | $424.36M | $395.12M | $358.73M | -1.7% |
| Total operating expense | $482.03M | $487.41M | $455.99M | $417.90M | -1.1% |
| Operating income | $341.15M | $366.94M | $342.83M | $347.19M | -7.0% |
| Net interest income | $7.00M | $12.83M | $3.16M | -$4.23M | -45.5% |
| Pre-tax income | $355.78M | $399.46M | $350.37M | $329.68M | -10.9% |
| Tax provision | $90.54M | $97.47M | $77.86M | $80.06M | -7.1% |
| Net income | $265.24M | $302.00M | $272.51M | $249.62M | -12.2% |
| Net income to common | $265.24M | $302.00M | $272.51M | $249.62M | -12.2% |
| Basic EPS | 18.42 | 20.10 | 18.11 | 16.72 | -8.4% |
| Diluted EPS | 18.34 | 19.89 | 17.93 | 16.53 | -7.8% |
| EBIT | $357.53M | $401.25M | $353.48M | $334.26M | -10.9% |
| EBITDA | $422.37M | $464.29M | $414.34M | $393.44M | -9.0% |
| Basic shares | 14.40M | 15.02M | 15.05M | 14.93M | -4.2% |
| Diluted shares | 14.46M | 15.19M | 15.20M | 15.10M | -4.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $74.52M | $178.35M | $263.96M | $74.13M | — | -58.2% |
| Cash & short-term investments | $74.52M | $178.35M | $263.96M | $74.13M | — | -58.2% |
| Accounts receivable | $182.57M | $171.16M | $181.51M | $139.41M | — | +6.7% |
| Inventory | $7.54M | $8.19M | $12.00M | $10.27M | — | -7.9% |
| Total current assets | $302.62M | $394.75M | $500.84M | $272.61M | — | -23.3% |
| Property, plant & equipment | $336.81M | $328.16M | $330.23M | $335.38M | — | +2.6% |
| Goodwill & intangibles | $749.76M | $758.95M | $675.28M | $681.02M | — | -1.2% |
| Total assets | $1.54B | $1.67B | $1.67B | $1.44B | — | -7.8% |
| Total current liabilities | $287.13M | $285.69M | $312.05M | $297.20M | — | +0.5% |
| Current debt | — | — | $15.70M | $5.00M | — | — |
| Long-term debt | — | — | — | $92.50M | $185.00M | — |
| Total debt | $143.76M | $140.84M | $139.41M | $247.01M | — | +2.1% |
| Total liabilities | $558.78M | $549.58M | $560.22M | $643.30M | — | +1.7% |
| Retained earnings | $2.96B | $2.72B | $2.45B | $2.20B | — | +8.6% |
| Shareholder equity | $979.40M | $1.12B | $1.11B | $798.72M | — | -12.5% |
| Working capital | $15.49M | $109.05M | $188.79M | -$24.59M | — | -85.8% |
| Net tangible assets | $229.64M | $360.04M | $432.60M | $117.69M | — | -36.2% |
| Shares issued | 37.59M | 37.42M | 37.18M | 36.80M | — | +0.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $265.24M | $302.00M | $272.51M | $249.62M | -12.2% |
| Depreciation & amortisation | $64.84M | $63.05M | $60.87M | $59.17M | +2.8% |
| Stock-based compensation | $32.67M | $32.03M | $30.08M | $26.25M | +2.0% |
| Change in working capital | $23.25M | $8.13M | -$39.31M | -$33.49M | +185.9% |
| Operating cash flow | $388.27M | $417.50M | $330.30M | $309.89M | -7.0% |
| Capital expenditure | -$62.80M | -$49.53M | -$56.85M | -$57.33M | -26.8% |
| Investing cash flow | -$59.34M | -$143.91M | -$60.64M | -$59.40M | +58.8% |
| Share buybacks | -$431.50M | -$361.39M | -$67.70M | -$114.52M | -19.4% |
| Dividends paid | -$31.70M | -$27.09M | -$23.50M | -$22.02M | -17.0% |
| Financing cash flow | -$432.77M | -$359.19M | -$79.83M | -$209.25M | -20.5% |
| Free cash flow | $325.48M | $367.97M | $273.44M | $252.56M | -11.5% |
| End cash position | $74.52M | $178.35M | $263.96M | $74.13M | -58.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | — | $657.51M | $639.34M | $624.90M | $618.80M | $646.94M | — |
| Operating revenue | — | $659.48M | $634.05M | $627.31M | $620.45M | $648.16M | — |
| Cost of revenue | — | $441.75M | $414.17M | $427.99M | $434.11M | $430.53M | — |
| Gross profit | — | $215.76M | $225.17M | $196.91M | $184.69M | $216.41M | — |
| Selling, general & admin | — | $114.32M | $105.50M | $105.78M | $99.41M | $105.59M | — |
| Total operating expense | — | $131.19M | $121.61M | $122.16M | $115.69M | $121.66M | — |
| Operating income | — | $84.58M | $103.56M | $74.75M | $69.00M | $94.76M | — |
| Net interest income | — | $378.00K | $1.04M | $2.10M | $2.11M | $1.75M | — |
| Pre-tax income | — | $88.84M | $105.44M | $83.54M | $71.11M | $95.67M | — |
| Tax provision | — | $22.54M | $28.69M | $19.31M | $18.62M | $23.92M | — |
| Net income | — | $66.30M | $76.75M | $64.24M | $52.49M | $71.76M | — |
| Net income to common | — | $66.30M | $76.75M | $64.24M | $52.49M | $71.76M | — |
| Basic EPS | 5.14 | 4.85 | 5.48 | 4.46 | 3.60 | — | +6.0% |
| Diluted EPS | 5.13 | 4.84 | 5.48 | 4.46 | 3.57 | — | +6.0% |
| EBIT | — | $89.35M | $105.97M | $84.00M | $71.56M | $96.00M | — |
| EBITDA | — | $106.22M | $122.30M | $100.23M | $87.82M | $112.02M | — |
| Basic shares | 13.17M | 13.68M | 13.99M | 14.39M | 14.59M | — | -3.7% |
| Diluted shares | 13.20M | 13.69M | 14.01M | 14.41M | 14.70M | — | -3.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | $16.86M | $74.52M | $129.75M | $249.90M | $173.88M | — |
| Cash & short-term investments | — | $16.86M | $74.52M | $129.75M | $249.90M | $173.88M | — |
| Accounts receivable | — | $215.48M | $182.57M | $215.57M | $184.88M | $285.87M | — |
| Inventory | — | $7.21M | $7.54M | $8.24M | $9.15M | $7.79M | — |
| Total current assets | — | $274.06M | $302.62M | $395.24M | $491.38M | $502.38M | — |
| Property, plant & equipment | — | $341.33M | $336.81M | $332.30M | $334.23M | $330.83M | — |
| Goodwill & intangibles | — | $767.92M | $749.76M | $751.92M | $754.36M | $756.87M | — |
| Total assets | — | $1.54B | $1.54B | $1.62B | $1.72B | $1.73B | — |
| Total current liabilities | — | $321.42M | $287.13M | $292.04M | $263.89M | $290.56M | — |
| Long-term debt | — | $91.20M | — | — | — | — | — |
| Total debt | — | $236.93M | $143.76M | $141.47M | $145.56M | $145.06M | — |
| Total liabilities | — | $687.82M | $558.78M | $546.94M | $519.36M | $544.75M | — |
| Retained earnings | — | $3.01B | $2.96B | $2.89B | $2.83B | $2.79B | — |
| Shareholder equity | — | $847.99M | $979.40M | $1.08B | $1.20B | $1.18B | — |
| Working capital | — | -$47.35M | $15.49M | $103.20M | $227.49M | $211.83M | — |
| Net tangible assets | — | $80.08M | $229.64M | $324.77M | $444.13M | $424.89M | — |
| Shares issued | 13.07M | 37.66M | 37.59M | 37.59M | 37.65M | — | -65.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $66.30M | $76.75M | $64.24M | $52.49M | $71.76M | -13.6% |
| Depreciation & amortisation | $16.87M | $16.33M | $16.23M | $16.26M | $16.02M | +3.3% |
| Stock-based compensation | $9.25M | $8.30M | $6.07M | $9.22M | $9.09M | +11.5% |
| Change in working capital | -$965.00K | $20.54M | -$2.29M | $57.61M | -$52.60M | -104.7% |
| Operating cash flow | $88.22M | $133.53M | $83.39M | $138.61M | $32.74M | -33.9% |
| Capital expenditure | -$17.12M | -$16.35M | -$17.36M | -$15.81M | -$13.28M | -4.7% |
| Investing cash flow | -$37.79M | -$15.95M | -$14.23M | -$15.48M | -$13.67M | -136.9% |
| Share buybacks | -$190.04M | -$174.56M | -$180.78M | -$42.95M | -$33.22M | -8.9% |
| Dividends paid | -$8.17M | -$8.50M | -$8.65M | -$7.22M | -$7.33M | +3.8% |
| Financing cash flow | -$108.09M | -$172.82M | -$189.31M | -$47.10M | -$23.54M | +37.5% |
| Free cash flow | $71.10M | $117.19M | $66.03M | $122.80M | $19.46M | -39.3% |
| End cash position | $16.86M | $74.52M | $129.75M | $249.90M | $173.88M | -77.4% |
Options analytics
Put / call volume
0.01
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
430.00
-15.7% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
274
Contracts, this expiry
Put volume
4
Contracts, this expiry
Heaviest call OI
500.00
0 contracts
Heaviest put OI
430.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 5.60 | 6.06 | +8.2% |
| Mar 2026 | 5.30 | 5.65 | +6.6% |
| Dec 2025 | 7.03 | 6.42 | -8.7% |
| Sep 2025 | 5.37 | 5.27 | -1.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 6.44 | 5 | $685.04M | +9.6% |
| Next quarter | 7.37 | 5 | $705.34M | +10.3% |
| Current year | 25.49 | 5 | $2.72B | +7.6% |
| Next year | 27.52 | 5 | $2.89B | +6.1% |
Analyst targets & ownership
Mean target$571.60
High target$650.00
Low target$520.00
Implied upside12.11%
Analyst count5
ConsensusBUY
Strong buy / Buy0 / 2
Hold3
Sell / Strong sell0 / 0
Held by insiders1.94%
Held by institutions106.51%
Institutions holding699
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
506.89
+0.58% from price
SMA 20
507.74
+0.41% from price
SMA 50
523.39
-2.59% from price
SMA 100
491.06
+3.82% from price
SMA 200
455.93
+11.82% from price
EMA 12
508.17
+0.33% from price
EMA 26
511.17
-0.26% from price
EMA 50
509.41
+0.08% from price
RSI (14)
48.7
Neutral
MACD (12,26,9)
-3.00
Hist 1.07
ATR (14)
12.21
2.39% of price
Realised vol 30D
21.2%
Annualised
Bollinger upper
520.80
20, 2σ
Bollinger lower
494.68
20, 2σ
50 / 200 cross
Golden
523.39 vs 455.93
Trend bias
Above 200
+11.82%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.04
Less volatile than market
Correlation to SPY
0.02
Largely independent
Realised vol 30D
21.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-23.0%
Peak to trough
Max drawdown 5Y
-43.4%
Peak to trough
ATR 14
12.21
2.39% of price
Beta (reported)
0.51
5Y monthly, from filing
Short interest
Shares short
653.25K
Prior 638.41K
Change vs prior
+2.3%
Shorts adding
% of float
5.89%
Normal
% of shares out
5.00%
Against total outstanding
Days to cover
4.8
Liquid
Float
11.85M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 25, 26 | UBS | INITIATED | — | Buy |
| Jul 31, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Jul 30, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Jul 9, 26 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Apr 27, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Feb 27, 26 | RBC Capital | DOWNGRADE | Outperform | Sector Perform |
| Feb 27, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Jan 22, 26 | Jefferies | DOWNGRADE | Buy | Hold |
| Nov 10, 25 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Sep 10, 25 | B of A Securities | MAINTAINED | Buy | Buy |
| Sep 2, 25 | Jefferies | UPGRADE | Hold | Buy |
| Jul 31, 25 | RBC Capital | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate$2.80 / yr
Forward yield0.55%
5-year avg yield0.33%
Payout ratio12.07%
Ex-dividend dateAug 17, 2026
Next pay dateSep 3, 2026
Last split2:1
Split dateMay 12, 2005
SEC filings
Periodic Financial Reports
10-Q · 2026-07-31
Corporate Changes & Voting Matters
8-K · 2026-07-28
Annual report of employee stock purchase
11-K · 2026-06-24
Corporate Changes & Voting Matters
8-K · 2026-05-19
Periodic Financial Reports
10-Q · 2026-04-28
Corporate Changes & Voting Matters
8-K · 2026-04-23
Corporate Changes & Voting Matters
8-K · 2026-04-13
Proxy Statements
DEFR14A · 2026-04-09
Headlines
Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
GlobeNewswire · 6d ago
3 Small-Cap Stocks with Questionable Fundamentals
StockStory · 6d ago
Chemed Insider Sold Shares Worth $1,026,900, According to a Recent SEC Filing
MT Newswires · 6d ago
Chemed (CHE) Stock May Be 26% Undervalued On Franchise Territory Deal
Simply Wall St. · 11d ago
UBS Initiates Chemed at Buy With $650 Price Target
MT Newswires · 12d ago
Chemed (CHE) Buys a $60.6M Roto-Rooter Franchise. Can Ownership Lift Returns?
Insider Monkey · 14d ago
Chemed Insider Sold Shares Worth $1,002,800, According to a Recent SEC Filing
MT Newswires · 16d ago
Chemed Unit Buys Franchise Territory in California
MT Newswires · 20d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.